(E)-5-((5-bromo-1H-indol-3-yl)methylene)-2-iminoimidazolidin-4-one

ID: ALA2442272

Max Phase: Preclinical

Molecular Formula: C12H9BrN4O

Molecular Weight: 305.13

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  N=C1NC(=O)/C(=C\c2c[nH]c3ccc(Br)cc23)N1

Standard InChI:  InChI=1S/C12H9BrN4O/c13-7-1-2-9-8(4-7)6(5-15-9)3-10-11(18)17-12(14)16-10/h1-5,15H,(H3,14,16,17,18)/b10-3+

Standard InChI Key:  YTYPKXGCVRKLLN-XCVCLJGOSA-N

Molfile:  

     RDKit          2D

 18 20  0  0  0  0  0  0  0  0999 V2000
   16.9019   -4.4241    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4654   -5.1193    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.6734   -4.9224    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6121   -4.1035    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3762   -3.7985    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.0446   -5.4507    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.7186   -4.3701    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.1882   -3.5195    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5580   -5.5511    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.3042   -5.2135    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0091   -3.5195    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4175   -4.2271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1882   -4.9389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0091   -4.9389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7757   -4.2271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8317   -3.8505    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2194   -4.3994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7811   -2.8109    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  1  5  1  0
  3  6  2  0
  1  7  2  0
 12 11  1  0
 17 12  1  0
  4 16  2  0
 10 17  2  0
 11  8  2  0
 15 13  2  0
 12 14  2  0
 13 14  1  0
  9 10  1  0
  8 15  1  0
  9 14  1  0
 16 17  1  0
  8 18  1  0
M  END

Alternative Forms

  1. Parent:

    ALA2442272

    ---

Associated Targets(Human)

HTR6 Tchem Serotonin 6 (5-HT6) receptor (9749 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR7 Tclin Serotonin 7 (5-HT7) receptor (5576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR5A Tchem Serotonin 5a (5-HT5a) receptor (1433 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2B Tclin Serotonin 2b (5-HT2b) receptor (10323 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2C Tclin Serotonin 2c (5-HT2c) receptor (11471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Gallus gallus (1187 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Htr2a Serotonin 2a (5-HT2a) receptor (3540 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 305.13Molecular Weight (Monoisotopic): 303.9960AlogP: 1.93#Rotatable Bonds: 1
Polar Surface Area: 80.77Molecular Species: NEUTRALHBA: 2HBD: 4
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 10.37CX Basic pKa: 2.34CX LogP: 1.67CX LogD: 1.67
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.61Np Likeness Score: -0.14

References

1. Lewellyn K, Bialonska D, Loria MJ, White SW, Sufka KJ, Zjawiony JK..  (2013)  In vitro structure-activity relationships of aplysinopsin analogs and their in vivo evaluation in the chick anxiety-depression model.,  21  (22): [PMID:24084296] [10.1016/j.bmc.2013.09.011]

Source